Drug Database
Back to search

Germany· DE-A57-8b48db2a9132eeb8

Vinblastin Stada

A vinblastine product containing vinblastine sulfate, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 14 of our 19 countries.

ATC L01CA01

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedVinblastin StadaATCL01CA01REGISTER NO.DE-A57-8b48db2a9132ee…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vinblastine sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vinblastine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01CA01 (vinblastine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search vinblastine products by name

Vinblastine · ATC L01CA01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinblastine costs, country by country.

Normalised to the WHO defined daily dose (11.61 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Vinblastine · price per daily dose (11.61 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$56.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Vinblastine Sulfate
Manufacturer
Stadapharm Gmbh
Country
Germany (DE)
ATC code
L01CA01
ATC class
Vinblastine
Defined daily dose
11.61 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

416 interactions on record for vinblastine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check vinblastine against other medicinesHow interaction checks work

Vinblastine · interactions on record

416 records

  • 61 severe
  • 303 moderate
  • 24 minor
  • 28 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinblastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinblastine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Velbe
  • Belgium · Vinblastine Teva
  • Czechia · Vinblastin Teva
  • Denmark · Velbe
  • Estonia · Vinblastine Teva
  • Spain · Vinblastina Stada
  • Finland · Velbe
  • France · Velbe
  • United Kingdom (Northern Ireland) · Vinblastine Sulfate Hospira Uk
  • Ireland · Vinblastine Sulfate Pfizer Healthcare Ireland
  • Italy · Velbe
  • Lithuania · Vinblastine Teva
  • Luxembourg · Vinblastine Teva
  • Latvia · Vinblastine Teva
  • Malta · Vinblastine Sulfate Pfizer Hellas
  • Netherlands · Vinblastinesulfaat Pch
  • Norway · Velbe
  • Portugal · Solblastin
  • Romania · Vinblastină Teva
  • Sweden · Velbe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f457facb-7353-4ff4-b62b-b616f3186dbf
GET /v1/drugs/f457facb-7353-4ff4-b62b-b616f3186dbf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Vinblastine Sulfate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about vinblastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console